Premium
Anti‐interleukin‐8 autoantibody in the tracheobronchial aspirate of infants with chronic lung disease
Author(s) -
Takasaki Jiro,
Ogawa Yunosuke
Publication year - 2001
Publication title -
pediatrics international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.49
H-Index - 63
eISSN - 1442-200X
pISSN - 1328-8067
DOI - 10.1046/j.1442-200x.2001.01341.x
Subject(s) - medicine , autoantibody , ards , respiratory distress , lung , gastroenterology , immunology , interleukin , antibody , cytokine , anesthesia
Background: A high concentration of interleukin (IL)‐8 has been observed in the tracheobronchial aspirate of infants with chronic lung disease (CLD), although the pattern varies depending on the type of CLD. Alveolar fluid from patients with adult respiratory distress syndrome (ARDS) also contains an elevated level of IL‐8. Recently, the presence of anti‐IL‐8 autoantibody was demonstrated in the alveolar fluid from patients with ARDS.Methods and Results: The concentration of anti‐IL‐8 autoantibody in the tracheobronchial aspirate of infants with CLD was measured in order to discover whether there was any correlation with the concentration of IL‐8. Similar to IL‐8 concentration, the anti‐IL‐8 IgM antibody concentration in all infants with CLD following intrauterine infection was already high during the first 48 h. However, the concentration in infants with CLD following respiratory distress syndrome began to increase after 11 days of life, in contrast with the rise in IL‐8 between 48 h after birth and day 5.Conclusions: The presence of anti‐IL‐8 autoantibody may provide a mechanism that limits the bioavailability of free IL‐8 in the lungs. In addition, the time lag between the increase in IL‐8 and anti‐IL‐8 IgM autoantibody demonstrated in the present study could be used to estimate the time when the inflammation begins, even if the IL‐8 concentration is already high.